These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 13680553)

  • 1. Plasma endothelin-1 levels and clinical correlates in patients with chronic heart failure.
    Kinugawa T; Kato M; Ogino K; Osaki S; Igawa O; Hisatome I; Shigemasa C
    J Card Fail; 2003 Aug; 9(4):318-24. PubMed ID: 13680553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure.
    Isnard R; Pousset F; Chafirovskaïa O; Carayon A; Hulot JS; Thomas D; Komajda M
    Am Heart J; 2003 Oct; 146(4):729-35. PubMed ID: 14564330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical correlates of elevated plasma natriuretic peptides and Big endothelin-1 in a population of ambulatory patients with heart failure. A substudy of the Italian Network on Congestive Heart Failure (IN-CHF) registry. IN-CHF Investigators.
    Masson S; Gorini M; Salio M; Lucci D; Latini R; Maggioni AP
    Ital Heart J; 2000 Apr; 1(4):282-8. PubMed ID: 10824729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure.
    Selvais PL; Robert A; Ahn S; van Linden F; Ketelslegers JM; Pouleur H; Rousseau MF
    J Card Fail; 2000 Sep; 6(3):201-7. PubMed ID: 10997745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between B-type natriuretic peptide levels and ventilatory response during cardiopulmonary exercise test in patients with chronic heart failure.
    Scardovi AB; Coletta C; Aspromonte N; Perna S; Infusino T; Carunchio A; D'Errigo P; Seccareccia F; De Maria R; Greggi M; Di Giacomo T; Ricci R; Ceci V
    Minerva Cardioangiol; 2005 Aug; 53(4):313-20. PubMed ID: 16177675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal rhythmic oscillations of atrial natriuretic peptide and brain natriuretic peptide in heart failure.
    Bentzen H; Pedersen RS; Pedersen HB; Nyvad O; Pedersen EB
    Clin Sci (Lond); 2003 Mar; 104(3):303-12. PubMed ID: 12605591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlates of B-type natriuretic peptide and 6-min walk in heart failure patients.
    Hogenhuis J; Jaarsma T; Voors AA; Hillege HL; Lesman I; van Veldhuisen DJ
    Int J Cardiol; 2006 Mar; 108(1):63-7. PubMed ID: 16516699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline and serial neurohormones in patients with congestive heart failure treated with and without bucindolol: results of the neurohumoral substudy of the Beta-Blocker Evaluation of Survival Study (BEST).
    Frantz RP; Lowes BD; Grayburn PA; White M; Krause-Steinrauf H; Krishnan V; Uyeda L; Burnett JC;
    J Card Fail; 2007 Aug; 13(6):437-44. PubMed ID: 17675057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.
    Passino C; Maria Sironi A; Favilli B; Poletti R; Prontera C; Ripoli A; Lombardi M; Emdin M
    Int J Cardiol; 2005 Sep; 104(1):39-45. PubMed ID: 16137508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmented response in plasma brain natriuretic peptide to dynamic exercise in patients with left ventricular dysfunction and congestive heart failure.
    Kato M; Kinugawa T; Ogino K; Endo A; Osaki S; Igawa O; Hisatome I; Shigemasa C
    J Intern Med; 2000 Oct; 248(4):309-15. PubMed ID: 11086641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain natriuretic peptide kinetics during dynamic exercise in patients with chronic heart failure.
    Krüger S; Graf J; Merx MW; Stickel T; Kunz D; Hanrath P; Janssens U
    Int J Cardiol; 2004 May; 95(1):49-54. PubMed ID: 15159038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased circulating big endothelin-1, endothelin-1 and atrial natriuretic peptide in infants and children with heart failure secondary to congenital heart disease.
    Yeh JL; Hsu JH; Dai ZK; Liou SF; Chen IJ; Wu JR
    Int J Cardiol; 2005 Sep; 104(1):15-20. PubMed ID: 16055212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between plasma levels of cardiac natriuretic peptides and soluble Fas: plasma soluble Fas as a prognostic predictor in patients with congestive heart failure.
    Tsutamoto T; Wada A; Maeda K; Mabuchi N; Hayashi M; Tsutsui T; Ohnishi M; Fujii M; Matsumoto T; Yamamoto T; Takayama T; Kinoshita M
    J Card Fail; 2001 Dec; 7(4):322-8. PubMed ID: 11782855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of exercise testing on natriuretic peptide secretion in patients with atrial fibrillation.
    Wozakowska-Kapłon B; Opolski G
    Kardiol Pol; 2009 Mar; 67(3):254-61. PubMed ID: 19378231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In patients with severe systolic dysfunction, only brain natriuretic peptide is related to diastolic restrictive pattern.
    Catuzzo B; Ciancamerla F; Bobbio M; Longo M; Trevi GP
    J Card Fail; 2003 Aug; 9(4):303-10. PubMed ID: 13680551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of tumor necrosis factor-alpha correlate with the six-minute walk test results in patients with mild to moderate heart failure.
    Boffa GM; Zaninotto M; Nalli C; Forni M; Tiso E; Razzolini R; Plebani M
    Ital Heart J; 2004 Jan; 5(1):48-52. PubMed ID: 15080581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentration of BNP, endothelin 1, pro-inflammatory cytokines (TNF-alpha, IL-6) and exercise capacity in patients with heart failure treated with carvedilol.
    Nessler J; Nessler B; Kitliński M; Gackowski A; Piwowarska W; Stepniewski M
    Kardiol Pol; 2008 Feb; 66(2):144-51; discussion 152-3. PubMed ID: 18344152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma brain natriuretic peptide predicts short-term clinical outcome in heart failure patients with restrictive filling pattern.
    Feola M; Aspromonte N; Milani L; Bobbio M; Bardellotto S; Barro S; Giovinazzo P; Noventa F; Valle R
    J Card Fail; 2008 Jun; 14(5):420-5. PubMed ID: 18514935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlations between clinical presentation, brain natriuretic peptide, big endothelin-1, tumor necrosis factor-alpha and cardiac troponins in heart failure patients.
    Boffa GM; Zaninotto M; Bacchiega E; Nalli C; Forni M; Tiso E; Cacciavillani L; Razzolini R; Plebani M
    Ital Heart J; 2005 Feb; 6(2):125-32. PubMed ID: 15819505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is hormonal activation during exercise useful for risk stratification in patients with moderate congestive heart failure?
    de Groote P; Soudan B; Lamblin N; Rouaix-Emery N; Mc Fadden E; Meurice T; Mouquet F; Bauters C
    Am Heart J; 2004 Aug; 148(2):349-55. PubMed ID: 15309008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.